-
Je něco špatně v tomto záznamu ?
Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients
A. Ghosh, M. Mukherjee,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
757 (Sanc.)/ST/P/S&T/12G-21/2014 dated 27.11.14
Department of Science and Technology, Government of West Bengal
DST/INSPIRE Fellowship/2016/ IF160069 dated November 7,2016
Department of Science &Technology,New Delhi,Government of India
- MeSH
- adheziny Escherichia coli genetika metabolismus MeSH
- antibakteriální látky farmakologie MeSH
- asymptomatické nemoci MeSH
- dítě MeSH
- dospělí MeSH
- faktory virulence genetika metabolismus MeSH
- fylogeneze MeSH
- genomové ostrovy MeSH
- hospitalizace MeSH
- infekce vyvolané Escherichia coli epidemiologie mikrobiologie terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mnohočetná bakteriální léková rezistence * MeSH
- mutace MeSH
- proteiny fimbrií genetika metabolismus MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- uropatogenní Escherichia coli účinky léků genetika izolace a purifikace metabolismus MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Indie MeSH
Asymptomatic uropathogenic Escherichia coli (UPECs) are the leading cause of asymptomatic bacteriuria (ABU) in humans. So this study aimed to identify and characterize ABU UPECs from hospitalized patients of Kolkata, India, with respect to their antibiogram profile, phylogeny, pathogenicity islands, and virulence factor gene acquisition and FimH mutations in comparison to symptomatic UPECs. E. coli was detected biochemically in 44.44% (20/45) and 32.26% (20/62) of urine culture-positive asymptomatic and symptomatic hospitalized individuals respectively. Ninety-five percent of the asymptomatic isolates were multidrug resistant (MDR) compared to the symptomatic isolates (100%). Significant predominance of unknown phylogroup, pathogenicity island markers (PAI IV536, PAI I CFT073), and distribution patterns of different virulence factor genes respectively was evident among both groups. A significant correlation was observed between both groups of isolates with respect to their antibiotic resistances (except imipenem, amikacin, and nitrofurantoin), prevalence of phylogenetic groups and PAIs, and virulence factor gene (fimH, papC, papEF, papGII, iucD, and cnf1) acquisition. Pathoadaptive FimH adhesin mutations, especially hot spot mutation V27A, were detected in 80% asymptomatic isolates mostly reported in symptomatic ones worldwide. Moreover, this is the first study from India that reported incidence of "Unknown" phylogroup, pathogenicity island markers, and potentially pathoadaptive FimH mutations in asymptomatic UPECs isolated from hospitalized patients which further indicated that these ABU E. coli might have originated from their symptomatic counterparts due to unbridled use of unprescribed antibiotics. Therefore, this study demands antibiotic de-escalation along with regular and intricate monitoring at the molecular level for efficient management of ABU that addresses a major public health concern.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19041159
- 003
- CZ-PrNML
- 005
- 20191125121534.0
- 007
- ta
- 008
- 191125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-019-00685-4 $2 doi
- 035 __
- $a (PubMed)30835050
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ghosh, Arunita $u Department of Biochemistry and Medical Biotechnology, School of Tropical Medicine, 108, C.R Avenue, Kolkata, 700073, India.
- 245 10
- $a Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients / $c A. Ghosh, M. Mukherjee,
- 520 9_
- $a Asymptomatic uropathogenic Escherichia coli (UPECs) are the leading cause of asymptomatic bacteriuria (ABU) in humans. So this study aimed to identify and characterize ABU UPECs from hospitalized patients of Kolkata, India, with respect to their antibiogram profile, phylogeny, pathogenicity islands, and virulence factor gene acquisition and FimH mutations in comparison to symptomatic UPECs. E. coli was detected biochemically in 44.44% (20/45) and 32.26% (20/62) of urine culture-positive asymptomatic and symptomatic hospitalized individuals respectively. Ninety-five percent of the asymptomatic isolates were multidrug resistant (MDR) compared to the symptomatic isolates (100%). Significant predominance of unknown phylogroup, pathogenicity island markers (PAI IV536, PAI I CFT073), and distribution patterns of different virulence factor genes respectively was evident among both groups. A significant correlation was observed between both groups of isolates with respect to their antibiotic resistances (except imipenem, amikacin, and nitrofurantoin), prevalence of phylogenetic groups and PAIs, and virulence factor gene (fimH, papC, papEF, papGII, iucD, and cnf1) acquisition. Pathoadaptive FimH adhesin mutations, especially hot spot mutation V27A, were detected in 80% asymptomatic isolates mostly reported in symptomatic ones worldwide. Moreover, this is the first study from India that reported incidence of "Unknown" phylogroup, pathogenicity island markers, and potentially pathoadaptive FimH mutations in asymptomatic UPECs isolated from hospitalized patients which further indicated that these ABU E. coli might have originated from their symptomatic counterparts due to unbridled use of unprescribed antibiotics. Therefore, this study demands antibiotic de-escalation along with regular and intricate monitoring at the molecular level for efficient management of ABU that addresses a major public health concern.
- 650 _2
- $a adheziny Escherichia coli $x genetika $x metabolismus $7 D018830
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a asymptomatické nemoci $7 D058070
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a mnohočetná bakteriální léková rezistence $7 D024901
- 650 _2
- $a infekce vyvolané Escherichia coli $x epidemiologie $x mikrobiologie $x terapie $7 D004927
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a proteiny fimbrií $x genetika $x metabolismus $7 D036781
- 650 _2
- $a genomové ostrovy $7 D044404
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a fylogeneze $7 D010802
- 650 _2
- $a uropatogenní Escherichia coli $x účinky léků $x genetika $x izolace a purifikace $x metabolismus $7 D056689
- 650 _2
- $a faktory virulence $x genetika $x metabolismus $7 D037521
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Indie $x epidemiologie $7 D007194
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mukherjee, Mandira $u Department of Biochemistry and Medical Biotechnology, School of Tropical Medicine, 108, C.R Avenue, Kolkata, 700073, India. mandira_71@yahoo.com.
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 64, č. 4 (2019), s. 587-600
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30835050 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191125 $b ABA008
- 991 __
- $a 20191125121819 $b ABA008
- 999 __
- $a ok $b bmc $g 1468242 $s 1079766
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 64 $c 4 $d 587-600 $e 20190305 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- GRA __
- $a 757 (Sanc.)/ST/P/S&T/12G-21/2014 dated 27.11.14 $p Department of Science and Technology, Government of West Bengal
- GRA __
- $a DST/INSPIRE Fellowship/2016/ IF160069 dated November 7,2016 $p Department of Science &Technology,New Delhi,Government of India
- LZP __
- $a Pubmed-20191125